Search Results: Professional 156-587 Examinations Actual Questions - Easy and Guaranteed 156-587 Exam Success ☘ Easily obtain ⮆ 156-587 ⮄ for free download through ⇛ www.pdfvce.com ⇚ 💺156-587 Latest Exam Question
Should Social Media Be Part of Your Research Toolbox?
Social media has emerged as a valuable tool for diverse stakeholders across the research community. Learn about the risks and benefits in this article.
Coverage Analysis For Sites
Analyses tailored specifically to your institution’s guidelines and delivers the completed coverage analysis directly into your CTMS.
It’s Time for Sites to “Bring Your Own Technology” (BYOT)
The Bring Your Own Technology philosophy will produce synchronization between sites & sponsors, which improves both care & clinical outcomes.
Return of Research Results to Study Participants
Research into participant experiences has consistently shown their desire to learn the results of research to which they’ve contributed.
Clinical Research Training
Ensure your study teams, site networks, and investigators are ready for research with Advarra’s effective and engaging training solutions.
The Challenge of Unproven Regenerative Stem Cell Therapies
Stem cell clinics with unproven treatments are on the rise in the US. Learn how the FDA is working to bring new stem cell therapies under federal oversight.
Optimizing Site Initiation Timelines Through Centralized Processes
Learn how to optimize clinical trial initiation with centralized processes, intuitive intake forms, and custom reporting and streamline workflows for efficiency.
FDA’s September 2022 NPRMs: What They Mean for Academia and Industry
FDA’s new NPRMs would harmonize certain IRB regulations with the HHS Common Rule. Find out what this could mean for sites and sponsors.
FDA Guidance Offers New Flexibility to Biotechs in Cell and Gene Therapy
FDA recently released new guidance, potentially impacting early-phase cell and gene therapy trials.
Shifting Sands: The Complexities and Uncertainties of the Evolving US Regulatory, Policy, and Scientific Landscape for Biospecimen Research
Michele Russell-Einhorn co-authored Shifting Sands: The Complexities and Uncertainties of the Evolving US Regulatory, Policy, and Scientific Landscape.
The Importance of Keeping DSMBs Independent
By ensuring the DSMB is truly independent from study conduct, sponsors make trial data more trustworthy and enhance public confidence.
Advarra Acquires YourEncore, a Leading Provider of Drug Development and Commercialization Advisory and Consulting Services
Advarra Acquires YourEncore, a Leading Provider of Drug Development and Commercialization Advisory and Consulting Services YourEncore significantly expands Advarra’s consulting...
Subscribe to our monthly email
Receive updates monthly about webinars for CEUs, white papers, podcasts, and more.
Advancing Clinical Research: Safer, Smarter, Faster™
Copyright © 2024 Advarra. All Rights Reserved.